Function of Interferon Lambda Receptor 1 Variants in Stem Cell-Derived Hepatocytes with Abrogated Endogenous IFNLR1
Journal of Interferon & Cytokine Research · 2025
DOI: 10.1089/jir.2024.0262 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Interferon & Cytokine Research, 2025. Verfasst von Laura A Novotny und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Department of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA. Hauptthemen laut MEDLINE: Hepatocytes, Receptors, Interferon, Stem Cells, Hepatitis C, Chronic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS.
Abstract (Originalsprache)
Distinct transcriptional isoforms of the interferon lambda receptor 1 ( IFNLR1 ) are expressed in hepatocytes, but whether corresponding full-length and truncated IFNLR1 protein variants have discrete function is unclear. We quantitated IFNLR1 isoforms in liver and blood from individuals with chronic hepatitis C virus (HCV) infection before and after antiviral treatment, hypothesizing their relative expression may differentially change during resolution of virus-induced inflammation. We also expressed FLAG-tagged IFNLR1 variants in stem cell-derived hepatocytes (iHeps) with abrogated endogenous IFNLR1 to evaluate their function. IFNLR1 isoforms decreased in liver and blood during treatment of HCV, but no distinct pattern of decline was observed for any individual isoform. Expression of full-length IFNLR1 enabled lambda interferon (IFNL)-induced expression of antiviral and proinflammatory genes and augmented inhibition of hepatitis B virus (HBV) replication relative to wild-type (WT) iHeps. A noncanonical IFNLR1 variant missing part of the JAK1 binding domain enabled IFNLs to induce antiviral genes but could not support induction of proinflammatory genes or augmented HBV inhibition beyond that observed in WT iHeps with intact endogenous IFNLR1 . A secreted IFNLR1 variant had no identified function in iHeps lacking endogenous IFNLR1 . Although relative expression of individual IFNLR1 isoforms did not distinctly change during HCV treatment, functional studies in iHeps suggest IFNLR1 variants could function to titrate antiviral versus proinflammatory responses in hepatocytes in the context of viral hepatitis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Infectious Diseases, Department of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA.
- Department of Regenerative Medicine and Cell Biology, Medical University of South Carolina, Charleston, South Carolina, USA.
- Department of Pharmacology and Immunology, Medical University of South Carolina, Charleston, South Carolina, USA.
ORCID-Profile: Eric G Meissner
Förderung
- NIGMS NIH HHS
Zitieren
APA
Novotny, L. A., Kappler, C. S., & Meissner, E. G. (2025). Function of Interferon Lambda Receptor 1 Variants in Stem Cell-Derived Hepatocytes with Abrogated Endogenous IFNLR1. Journal of Interferon & Cytokine Research. https://doi.org/10.1089/jir.2024.0262
Vancouver
Novotny LA, Kappler CS, Meissner EG. Function of Interferon Lambda Receptor 1 Variants in Stem Cell-Derived Hepatocytes with Abrogated Endogenous IFNLR1. Journal of Interferon & Cytokine Research. 2025. doi:10.1089/jir.2024.0262
BibTeX
@article{Novotny2025,
author = {Novotny, Laura A and Kappler, Christiana S and Meissner, Eric G},
title = {Function of Interferon Lambda Receptor 1 Variants in Stem Cell-Derived Hepatocytes with Abrogated Endogenous IFNLR1},
journal = {Journal of Interferon & Cytokine Research},
year = {2025},
doi = {10.1089/jir.2024.0262}
}
EUVIMED